Advancing Adoption of Novel Safety Biomarkers into Drug Development through Voluntary Submission of Data at US FDA, EMA, and PMDA
Presenter – E Gribble Walker, M Brumfield, E H Dennis
Conference – Society of Toxicologists 2013 Annual Meeting
Related Posts
-
The Role of Safety Biomarkers in Predictive Toxicology -
Evaluation of Novel Biomarkers of Nephrotoxicity in Monkeys Treated with Gentamicin
-
Kidney Injury Biomarkers Lipocalin-2, Clusterin and Albumin, but Not Kidney Injury Molecule 1, Are More Sensitive Than Traditional Markers of Gentamicin-Induced Kidney Injury in Beagles
-
Evaluation of an In Vitro Model of Spermatogenesis for Predicting Testicular Toxicity
-
Rapid Immunoassay Development and Evaluation of ICAM-1 and E-Selectin As Potential Biomarkers of Vascular Injury in Rats